Novel approaches to study the involvement of α7-nAChR in human diseases

Eleonora Palma, Luca Conti, Cristina Roseti, Cristina Limatola

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The alpha7 nicotinic acetylcholine receptor (α7 nAChR) is widely distributed in the human brain and has been implicated in a number of human central nervous system (CNS) diseases, including Alzheimer's and Parkinson's disease, schizophrenia and autism. Recently, new roles for α7 nAChRs in lung cancer and heart disease have been elucidated. Despite the importance of this receptor in human pathology, many technical difficulties are still encountered when investigating the role of α7 nAChRs. Electrophysiological analysis of the receptor upon heterologous expression or in human tissues was limited by the fast desensitization of α7-mediated nicotinic currents and by tissue availability. In addition, animal models for the human diseases related to α7 nAChRs have long been unavailable. The recent development of new imaging and analysis approaches such as PET and receptor microtransplantation have rendered the study of α7 nAChRs increasingly feasible, paving new roads to the design of therapeutic drugs. This review summarizes the current knowledge and recent findings obtained by these novel approaches.

Original languageEnglish
Pages (from-to)579-586
Number of pages8
JournalCurrent Drug Targets
Volume13
Issue number5
Publication statusPublished - May 2012

Fingerprint

alpha7 Nicotinic Acetylcholine Receptor
Tissue
Neurology
Pathology
Animal Disease Models
Drug Design
Central Nervous System Diseases
Brain
Autistic Disorder
Animals
Lung Diseases
Availability
Parkinson Disease
Heart Diseases
Lung Neoplasms
Schizophrenia
Alzheimer Disease
Imaging techniques
Pharmaceutical Preparations
Therapeutics

Keywords

  • Calcium detection
  • Micro-transplantation
  • Pet

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Novel approaches to study the involvement of α7-nAChR in human diseases. / Palma, Eleonora; Conti, Luca; Roseti, Cristina; Limatola, Cristina.

In: Current Drug Targets, Vol. 13, No. 5, 05.2012, p. 579-586.

Research output: Contribution to journalArticle

@article{f2fe85c19c2b4960b7786a70186e82bb,
title = "Novel approaches to study the involvement of α7-nAChR in human diseases",
abstract = "The alpha7 nicotinic acetylcholine receptor (α7 nAChR) is widely distributed in the human brain and has been implicated in a number of human central nervous system (CNS) diseases, including Alzheimer's and Parkinson's disease, schizophrenia and autism. Recently, new roles for α7 nAChRs in lung cancer and heart disease have been elucidated. Despite the importance of this receptor in human pathology, many technical difficulties are still encountered when investigating the role of α7 nAChRs. Electrophysiological analysis of the receptor upon heterologous expression or in human tissues was limited by the fast desensitization of α7-mediated nicotinic currents and by tissue availability. In addition, animal models for the human diseases related to α7 nAChRs have long been unavailable. The recent development of new imaging and analysis approaches such as PET and receptor microtransplantation have rendered the study of α7 nAChRs increasingly feasible, paving new roads to the design of therapeutic drugs. This review summarizes the current knowledge and recent findings obtained by these novel approaches.",
keywords = "Calcium detection, Micro-transplantation, Pet",
author = "Eleonora Palma and Luca Conti and Cristina Roseti and Cristina Limatola",
year = "2012",
month = "5",
language = "English",
volume = "13",
pages = "579--586",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - Novel approaches to study the involvement of α7-nAChR in human diseases

AU - Palma, Eleonora

AU - Conti, Luca

AU - Roseti, Cristina

AU - Limatola, Cristina

PY - 2012/5

Y1 - 2012/5

N2 - The alpha7 nicotinic acetylcholine receptor (α7 nAChR) is widely distributed in the human brain and has been implicated in a number of human central nervous system (CNS) diseases, including Alzheimer's and Parkinson's disease, schizophrenia and autism. Recently, new roles for α7 nAChRs in lung cancer and heart disease have been elucidated. Despite the importance of this receptor in human pathology, many technical difficulties are still encountered when investigating the role of α7 nAChRs. Electrophysiological analysis of the receptor upon heterologous expression or in human tissues was limited by the fast desensitization of α7-mediated nicotinic currents and by tissue availability. In addition, animal models for the human diseases related to α7 nAChRs have long been unavailable. The recent development of new imaging and analysis approaches such as PET and receptor microtransplantation have rendered the study of α7 nAChRs increasingly feasible, paving new roads to the design of therapeutic drugs. This review summarizes the current knowledge and recent findings obtained by these novel approaches.

AB - The alpha7 nicotinic acetylcholine receptor (α7 nAChR) is widely distributed in the human brain and has been implicated in a number of human central nervous system (CNS) diseases, including Alzheimer's and Parkinson's disease, schizophrenia and autism. Recently, new roles for α7 nAChRs in lung cancer and heart disease have been elucidated. Despite the importance of this receptor in human pathology, many technical difficulties are still encountered when investigating the role of α7 nAChRs. Electrophysiological analysis of the receptor upon heterologous expression or in human tissues was limited by the fast desensitization of α7-mediated nicotinic currents and by tissue availability. In addition, animal models for the human diseases related to α7 nAChRs have long been unavailable. The recent development of new imaging and analysis approaches such as PET and receptor microtransplantation have rendered the study of α7 nAChRs increasingly feasible, paving new roads to the design of therapeutic drugs. This review summarizes the current knowledge and recent findings obtained by these novel approaches.

KW - Calcium detection

KW - Micro-transplantation

KW - Pet

UR - http://www.scopus.com/inward/record.url?scp=84860453355&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860453355&partnerID=8YFLogxK

M3 - Article

C2 - 22300023

AN - SCOPUS:84860453355

VL - 13

SP - 579

EP - 586

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 5

ER -